Association for Accessible Medicines
FDANonrulemakingFDA-2018-N-2065

Alternative or Streamlined Mechanisms for Complying with the Current Good Manufacturing Practice (CGMP) Requirements for Combination Products; Proposed List Pursuant to Section 3038(c) of the 21st Century Cures Act

RIN
Last modified
Sep 13, 2022
Comment window
closed 2877d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Sep 14, 2018 and Sep 14, 2018. 1 other organizations filed here. The comment window closed 2877d ago.

What Association for Accessible Medicines filed (1)

Sep 14, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-N-2065-0004

The Association for Accessible Medicines (AAM) is pleased to provide comments to the Food and Drug Administrations (FDAs or the Agencys) proposed list, entitled Alternative or Streamlined Mechanisms for Complying with the Current Good Manufacturing Practice Requirements for Combination Products

Abstract

No abstract recorded.

View on regulations.gov →